XML 106 R95.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Statements (Condensed Consolidating Statement Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Intercompany fee income (expense) $ 0 $ 0 $ 0
Interest income (expense) on intercompany receivable/payable 0 0 0
Net cash provided (used) by other operating activities 195,799 180,391 148,817
Net cash provided by operating activities 195,799 180,391 148,817
Acquisition of rental properties and other assets (53,175) (131,057) (135,112)
Proceeds from sale of real estate 1,700 0 0
Investment in unconsolidated joint ventures (3,970) (16,691) (1,677)
Cash paid related to Cappelli settlement 0 (4,586) 0
Investment in mortgage notes receivable (19,688) (5,696) (35,945)
Proceeds from Sale and Collection of Mortgage Notes Receivable 0 0 3,512
Payments to Acquire Notes Receivable 0 0 (4,108)
Proceeds from Sale and Collection of Notes Receivable 0 0 1,000
Investment in direct financing leases, net (2,113) (51,833) 0
Additions to properties under development (57,926) (4,934) (19,672)
Investment in intercompany notes payable 0 0 0
Advances to subsidiaries, net 0 0 0
Net cash used by investing activities of continuing operations (135,172) (214,797) (192,002)
Net cash used by other investing activities of discontinued operations (58) (112,977) 0
Net proceeds from sale of real estate from discontinued operations 224,912 7,456 0
Net cash used by investing activities 89,682 (320,318) (192,002)
Proceeds from long-term debt facilities 387,000 770,225 132,006
Principal payments on long-term debt (425,859) (616,494) (266,423)
Deferred financing fees paid (3,731) (11,609) (5,017)
Net proceeds from issuance of common shares 253 141,134 284,965
Redemption of preferred shares (80,030) 0 0
Impact of stock option exercises, net 966 (815) (805)
Proceeds from Payment of Shareholder Loan 0 281 0
Purchase of common shares for treasury (3,070) (2,182) (1,201)
Distributions paid to noncontrolling interests 0 10 (209)
Dividends paid to shareholders (157,844) (146,324) (126,907)
Net cash provided (used) by financing activities of continuing operations (282,315) 134,226 16,409
Net cash used by financing activities of discontinued operations 0 (6,271) (751)
Net cash provided by financing activities (282,315) 127,955 15,658
Effect of exchange rate changes on cash (317) 610 583
Net increase (decrease) in cash and cash equivalents 2,849 (11,362) (26,944)
Cash and cash equivalents at beginning of the year 11,776 23,138 50,082
Cash and cash equivalents at end of the year 14,625 11,776 23,138
Entertainment Properties Trust (Issuer) [Member]
     
Intercompany fee income (expense) 2,726 2,595 2,345
Interest income (expense) on intercompany receivable/payable 16,665 28,145 21,026
Net cash provided (used) by other operating activities (12,924) 4,206 1,868
Net cash provided by operating activities 6,467 34,946 25,239
Acquisition of rental properties and other assets (603) (4,286) (240)
Proceeds from sale of real estate 0    
Investment in unconsolidated joint ventures (2,773) (15,662) (64)
Cash paid related to Cappelli settlement   3,483  
Investment in mortgage notes receivable 0 0 0
Proceeds from Sale and Collection of Mortgage Notes Receivable     0
Payments to Acquire Notes Receivable     0
Proceeds from Sale and Collection of Notes Receivable     0
Investment in direct financing leases, net 0 0  
Additions to properties under development 0 0 0
Investment in intercompany notes payable 127,111 (42,801) (5,430)
Advances to subsidiaries, net 108,495 (218,024) (202,925)
Net cash used by investing activities of continuing operations 232,230 (277,290)  
Net cash used by other investing activities of discontinued operations 0 0  
Net proceeds from sale of real estate from discontinued operations 0 0  
Net cash used by investing activities 232,230 (277,290) (208,659)
Proceeds from long-term debt facilities 0 245,725 0
Principal payments on long-term debt 0 0 0
Deferred financing fees paid (396) (5,686) (75)
Net proceeds from issuance of common shares 253 141,134 284,965
Redemption of preferred shares (80,030)    
Impact of stock option exercises, net 966 (815) (805)
Proceeds from Payment of Shareholder Loan   281  
Purchase of common shares for treasury (3,070) (2,182) (1,201)
Distributions paid to noncontrolling interests   0 0
Dividends paid to shareholders (157,844) (146,324) (126,907)
Net cash provided (used) by financing activities of continuing operations   232,133 155,977
Net cash used by financing activities of discontinued operations   0 0
Net cash provided by financing activities (240,121) 232,133 155,977
Effect of exchange rate changes on cash 0 0 0
Net increase (decrease) in cash and cash equivalents (1,424) (10,211) (27,443)
Cash and cash equivalents at beginning of the year 3,356 13,567 41,010
Cash and cash equivalents at end of the year 1,932 3,356 13,567
Wholly-Owned Subsidiary Guarantors [Member]
     
Intercompany fee income (expense) 0 0 0
Interest income (expense) on intercompany receivable/payable 0 (12,756) (7,717)
Net cash provided (used) by other operating activities 120,103 99,172 67,403
Net cash provided by operating activities 120,103 86,416 59,686
Acquisition of rental properties and other assets (41,795) (124,623) (123,498)
Proceeds from sale of real estate 0    
Investment in unconsolidated joint ventures 0 0 0
Cash paid related to Cappelli settlement   0  
Investment in mortgage notes receivable (18,391) (5,696) (35,945)
Proceeds from Sale and Collection of Mortgage Notes Receivable     0
Payments to Acquire Notes Receivable     0
Proceeds from Sale and Collection of Notes Receivable     0
Investment in direct financing leases, net (2,113) (51,833)  
Additions to properties under development (35,385) (376) 0
Investment in intercompany notes payable (132,067) 38,072 0
Advances to subsidiaries, net (174,548) 188,298 219,931
Net cash used by investing activities of continuing operations (404,299) 43,842  
Net cash used by other investing activities of discontinued operations (58) (111,718)  
Net proceeds from sale of real estate from discontinued operations 205,936 0  
Net cash used by investing activities (198,421) (67,876) 60,488
Proceeds from long-term debt facilities 387,000 524,500 128,000
Principal payments on long-term debt (306,000) (535,100) (243,200)
Deferred financing fees paid (3,330) (5,870) (4,773)
Net proceeds from issuance of common shares 0 0 0
Redemption of preferred shares 0    
Impact of stock option exercises, net 0 0 0
Purchase of common shares for treasury 0 0 0
Distributions paid to noncontrolling interests   0 0
Dividends paid to shareholders 0 0 0
Net cash provided (used) by financing activities of continuing operations   (16,470) (119,973)
Net cash used by financing activities of discontinued operations   (1,348) 0
Net cash provided by financing activities 77,670 (17,818) (119,973)
Effect of exchange rate changes on cash (166) 286 (149)
Net increase (decrease) in cash and cash equivalents (814) 1,008 52
Cash and cash equivalents at beginning of the year 1,116 108 56
Cash and cash equivalents at end of the year 302 1,116 108
Non-Guarantor Subsidiaries [Member]
     
Intercompany fee income (expense) (2,726) (2,595) (2,345)
Interest income (expense) on intercompany receivable/payable (16,665) (15,389) (13,309)
Net cash provided (used) by other operating activities 88,620 77,013 79,546
Net cash provided by operating activities 69,229 59,029 63,892
Acquisition of rental properties and other assets (10,777) (2,148) (11,374)
Proceeds from sale of real estate 1,700    
Investment in unconsolidated joint ventures (1,197) (1,029) (1,613)
Cash paid related to Cappelli settlement   (8,069)  
Investment in mortgage notes receivable (1,297) 0 0
Proceeds from Sale and Collection of Mortgage Notes Receivable     3,512
Payments to Acquire Notes Receivable     (4,108)
Proceeds from Sale and Collection of Notes Receivable     1,000
Investment in direct financing leases, net 0 0  
Additions to properties under development (22,541) (4,558) (19,672)
Investment in intercompany notes payable 4,956 4,729 5,430
Advances to subsidiaries, net 66,053 29,726 (17,006)
Net cash used by investing activities of continuing operations 36,897 18,651  
Net cash used by other investing activities of discontinued operations 0 (1,259)  
Net proceeds from sale of real estate from discontinued operations 18,976 7,456  
Net cash used by investing activities 55,873 24,848 (43,831)
Proceeds from long-term debt facilities 0 0 4,006
Principal payments on long-term debt (119,859) (81,394) (23,223)
Deferred financing fees paid (5) (53) (169)
Net proceeds from issuance of common shares 0 0 0
Redemption of preferred shares 0    
Impact of stock option exercises, net 0 0 0
Proceeds from Payment of Shareholder Loan   0  
Purchase of common shares for treasury 0 0 0
Distributions paid to noncontrolling interests   10 (209)
Dividends paid to shareholders 0 0 0
Net cash provided (used) by financing activities of continuing operations   (81,437) (19,595)
Net cash used by financing activities of discontinued operations   (4,923) (751)
Net cash provided by financing activities (119,864) (86,360) (20,346)
Effect of exchange rate changes on cash (151) 324 732
Net increase (decrease) in cash and cash equivalents 5,087 (2,159) 447
Cash and cash equivalents at beginning of the year 7,304 9,463 9,016
Cash and cash equivalents at end of the year $ 12,391 $ 7,304 $ 9,463